Home » Newsletters » BioWorld Science

BioWorld Science

July 19, 2002

View Archived Issues

Genzyme Biosurgery completes enrollment in HIF-1alpha gene therapy trial

Inhale and Chiron to develop second inhalable antibiotic under collaboration

Pharmion acquires U.S. marketing rights to Innohep

Angiostatin enters phase II program

Phase IIa trial initiated for ALT-711 in diastolic heart failure

Potential therapeutic for diabetes YM-178 advances to phase II

Selective Y5 blockade attenuates limbic epileptogenesis in rat model

RB-3007, a long-acting analgesic agent that acts by preventing the degradation of Met-enkephalin

Sigma-Tau compound proves safe and effective in dog model of acute ischemic heart failure

Antioxidant with cardioprotective properties under investigation at U. of Athens

Neuroprotection and modulation of nigrostriatal dopaminergic function with Neotrofin

Potential antiallergic effects described for chemically modified tetracycline at IUPHAR meeting

Neuroprotective effects of BN-82451 discussed at FENS Forum 2002

Prostaglandin analogues claimed by Taisho to prevent post-PTCA restenosis

New insulin secretagogues with good therapeutic profile

Toray presents selective delta opioid receptor ligands in recent patent

New antibacterial carbapenems identified at Meiji Seika

Yamanouchi scientists design series of anticoagulants

Novel antineoplastic antibiotics produced by Streptomyces

Busulfex to undergo clinical evaluation in Japan in hematopoietic stem cell transplantation

Antibacterial compounds discovered with affinity for penicillin receptors

DPC-817 effective against zidovudine- and lamivudine-resistant HIV variants

TNFerade enters phase IIb trial in advanced pancreatic cancer

NuvaRing launched as first vaginal birth control ring

Versicor and Pharmacia extend antibiotics collaboration

Schering AG completes Leukine acquisition

ACH-126443 enters phase II program in HIV/AIDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...